← SynDRA
LGD-6972
SynDRA canonical compound SYN0039615 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | GCGR |
|---|
| Mechanism of action | glucagon receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- glucagon receptor antagonist
- GCGR ANTAGONIST
Cross-references
Synonyms
- MB-11262
- 6IJ842I0Z2
- RefChem:153261
- MFCD28411370
- UNII-6IJ842I0Z2
- orb1709263
- SCHEMBL13494501
- C43H46N2O5S
- GTPL13314
- LGD6972
- RVT1502
- EX-A1650
- HYB98909
- RVT-1502
- LGD-6972?
- AKOS040733596
- CS-6449
- DA-74986
- HY-12525
- MS-31172
- Compound 15 [WO2019160940A1]
- G14476
- T11845
- LGD-6972; LGD 6972; LGD6972; MB-11262; MB 11262; MB11262
- 2-[[4-[(2R)-2-[4-(4-tert-butylphenyl)phenyl]-3-oxo-3-[4-(2,4,6-trimethylphenyl)anilino]propyl]benzoyl]amino]ethanesulfonic acid
- UNII-C704VNP688
- SCHEMBL31357392
- C704VNP688
- LGD-6972 sodium
- SCHEMBL31357391
Look up LGD-6972 in the interactive SynDRA portal →